Cassava Sciences is a startup based in the United States.
Cassava Sciences is a company headquartered in the United States.
Cassava Sciences is a clinical-stage biotechnology company developing therapies for neurodegenerative diseases, primarily Alzheimer’s disease, and is developing the drug candidate simufilam.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.